Investing Center Preview – Manage your investments and watch your net worth grow.
BIO.B:NYSE – Large Cap Stock ()
Bio Rad Laboratories Inc – BIO.B Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
241.99 | 0.00 (0.00%) | 241.99 - 359.22 | 0.0 |
Market data as of 11:42AM 03/31/25. Quotes are delayed by at least 15 min.
Overview - BIO.B
Open | -- |
---|---|
Previous Close | 241.99 |
Day's Range | -- - -- |
Market Cap | 1.2B |
Avg Volume (10 Day) | 114.0 |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -6.814 |
Dividend Yield | No Dividend |
One-Click Scorecard - BIO.B


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Pass |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Pass |
Increased shareholder value? | Fail |
Consistently increased owner earnings? | Pass |
Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - BIO.B
No news headlines available for BIO.B
Industry Position - BIO.B
BIO.B | Industry Range | |
---|---|---|
Revenue Growth (1yr) | -3.92% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.21 | |
LT Debt/Equity | 0.20 | |
Earnings Yield | -- | |
Price/Sales | 2.66 |
Competitors - BIO.B
Company | Last | Change |
---|
Data is delayed by at least 15 min.